Gopal L. Khatik

2.0k total citations
107 papers, 1.6k citations indexed

About

Gopal L. Khatik is a scholar working on Organic Chemistry, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gopal L. Khatik has authored 107 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Organic Chemistry, 31 papers in Molecular Biology and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gopal L. Khatik's work include Synthesis and biological activity (22 papers), Natural Antidiabetic Agents Studies (16 papers) and Computational Drug Discovery Methods (16 papers). Gopal L. Khatik is often cited by papers focused on Synthesis and biological activity (22 papers), Natural Antidiabetic Agents Studies (16 papers) and Computational Drug Discovery Methods (16 papers). Gopal L. Khatik collaborates with scholars based in India, Australia and Malaysia. Gopal L. Khatik's co-authors include Raj Kumar, Asit K. Chakraborti, Vipin A. Nair, Manish Vyas, Paranjeet Kaur, Surendra Kumar Nayak, Varun Kumar, Amit Mittal, Ashish Suttee and Gaurav Sharma and has published in prestigious journals such as Journal of Controlled Release, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Gopal L. Khatik

96 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gopal L. Khatik India 23 831 446 185 121 115 107 1.6k
Aakash Deep India 24 1.0k 1.2× 453 1.0× 70 0.4× 135 1.1× 100 0.9× 88 1.8k
Atish T. Paul India 17 818 1.0× 542 1.2× 135 0.7× 122 1.0× 279 2.4× 66 1.6k
Somayeh Mojtabavi Iran 22 752 0.9× 393 0.9× 396 2.1× 143 1.2× 93 0.8× 107 1.4k
K. Sreedhara Ranganath Pai India 26 750 0.9× 593 1.3× 110 0.6× 147 1.2× 223 1.9× 145 2.1k
Md Rafi Haider India 16 1.1k 1.3× 631 1.4× 72 0.4× 89 0.7× 126 1.1× 20 1.9k
E. J. Tavares da Silva Portugal 21 404 0.5× 576 1.3× 108 0.6× 102 0.8× 205 1.8× 62 1.6k
Muhammad Athar Abbasi Pakistan 20 646 0.8× 440 1.0× 124 0.7× 188 1.6× 219 1.9× 184 1.4k
Hinna Hamid India 23 827 1.0× 503 1.1× 86 0.5× 109 0.9× 231 2.0× 78 1.6k
Aneela Maalik Pakistan 20 532 0.6× 326 0.7× 74 0.4× 127 1.0× 184 1.6× 51 1.2k
M. J. Nanjan India 20 448 0.5× 757 1.7× 222 1.2× 114 0.9× 167 1.5× 85 2.1k

Countries citing papers authored by Gopal L. Khatik

Since Specialization
Citations

This map shows the geographic impact of Gopal L. Khatik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gopal L. Khatik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gopal L. Khatik more than expected).

Fields of papers citing papers by Gopal L. Khatik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gopal L. Khatik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gopal L. Khatik. The network helps show where Gopal L. Khatik may publish in the future.

Co-authorship network of co-authors of Gopal L. Khatik

This figure shows the co-authorship network connecting the top 25 collaborators of Gopal L. Khatik. A scholar is included among the top collaborators of Gopal L. Khatik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gopal L. Khatik. Gopal L. Khatik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Datusalia, Ashok Kumar, et al.. (2025). Network pharmacology exploring the mechanistic role of indirubin phytoconstituent from Indigo naturalis targeting GSK-3 β in Alzheimer’s disease. Journal of Biomolecular Structure and Dynamics. 43(18). 10959–10972.
4.
5.
Datusalia, Ashok Kumar, et al.. (2024). Roemerine, a Phytoconstituent of Annona senegalensis, Targets MAO-A in Alzheimer’s Disease: Network Pharmacology Integrated with Molecular Docking and Dynamics Studies. Journal of Computational Biophysics and Chemistry. 23(8). 1025–1037. 2 indexed citations
6.
Verma, Surajpal, et al.. (2022). Nanoformulations of quercetin: a potential phytochemical for the treatment of uv radiation induced skin damages. Brazilian Journal of Pharmaceutical Sciences. 58. 2 indexed citations
7.
Choudhary, Neeraj, et al.. (2021). Evaluation of Acute toxicity, In-vitro, In-vivo Antidiabetic Potential of the Flavonoid Fraction of the plant Chenopodium album L. Pharmacognosy Journal. 13(3). 765–779. 12 indexed citations
8.
Choudhary, Neeraj, et al.. (2021). In vitro anthelmintic activity of Chenopodium album and in-silico prediction of mechanistic role on Eisenia foetida. Heliyon. 7(1). e05917–e05917. 12 indexed citations
9.
Kapoor, Bhupinder, Monica Gulati, Sachin Kumar Singh, et al.. (2020). High-Performance Liquid Chromatography and Liquid Chromatography/Mass Spectrometry Studies on Stress Degradation Behavior of Sulfapyridine and Development of a Validated, Specific, Stability-Indicating HPLC Assay Method. Assay and Drug Development Technologies. 18(3). 119–133. 15 indexed citations
10.
Khatik, Gopal L., et al.. (2019). Recent advancement over traditional drug in the treatment of hypertension. International Journal for Advance Research and Development. 4(1). 58–61. 1 indexed citations
11.
Singh, Sachin Kumar, Gopal L. Khatik, Bhupinder Kapoor, et al.. (2019). Quality by Design-Based Crystallization of Curcumin Using Liquid Antisolvent Precipitation: Micromeritic, Biopharmaceutical, and Stability Aspects. Assay and Drug Development Technologies. 18(1). 11–33. 17 indexed citations
12.
Sharma, Neha, Saurabh Satija, Meenu Mehta, et al.. (2019). Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update. Current Pharmaceutical Design. 25(23). 2510–2525. 66 indexed citations
13.
Singh, Amrit Pal, Gopal L. Khatik, Vijay Mishra, et al.. (2019). FORMULATION DEVELOPMENT AND IN VITRO ANTIOXIDANT AND ANTIDIABETIC EVALUATION OF ERIOBOTRYA JAPONICA BASED SELF NANO EMULSIFYING DRUG DELIVERY SYSTEM. International Journal of Applied Pharmaceutics. 313–319. 4 indexed citations
14.
Vyas, Manish, Surendra Kumar Nayak, Ashish Suttee, et al.. (2019). An Insight of Alpha-amylase Inhibitors as a Valuable Tool in the Management of Type 2 Diabetes Mellitus. Current Diabetes Reviews. 16(2). 117–136. 56 indexed citations
15.
Khatik, Gopal L., et al.. (2019). Cancer Immunotherapy: An Effective Tool in Cancer Control and Treatment. Current Cancer Therapy Reviews. 16(1). 62–69. 3 indexed citations
16.
Kumar, Shubham, Gopal L. Khatik, & Amit Mittal. (2018). In silico Molecular Docking Study to Search New SGLT2 Inhibitor based on Dioxabicyclo[3.2.1] Octane Scaffold. Current Computer - Aided Drug Design. 16(2). 145–154. 23 indexed citations
17.
Yadav, Ankit, Varun Garg, Monica Gulati, et al.. (2018). DESIGN AND PERFORMANCE VERIFICATION OF NEWLY DEVELOPED DISPOSABLE STATIC DIFFUSION CELL FOR DRUG DIFFUSION/PERMEABILITY STUDIES. Asian Journal of Pharmaceutical and Clinical Research. 11(14). 1–1. 2 indexed citations
18.
Kaur, Barjinder Pal, et al.. (2017). Phytochemical Screening and Antioxidant Activity of Heracleum afghanicum Kitamura leaves. Research Journal of Pharmacy and Technology. 10(10). 3498–3498. 10 indexed citations
19.
Khatik, Gopal L.. (2015). DIABETES MELLITUS: RECENT ADVANCEMENT IN PPAR AGONISTS AS THERAPEUTIC AGENTS. International Journal of Pharma and Bio Sciences. 2 indexed citations
20.
Khatik, Gopal L., Jasmine Kaur, Varun Kumar, Kulbhushan Tikoo, & Vipin A. Nair. (2012). 1,2,4-Oxadiazoles: A new class of anti-prostate cancer agents. Bioorganic & Medicinal Chemistry Letters. 22(5). 1912–1916. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aakash Deep Breakdown of academic impact, for papers by Atish T. Paul Breakdown of academic impact, for papers by Somayeh Mojtabavi Breakdown of academic impact, for papers by K. Sreedhara Ranganath Pai Breakdown of academic impact, for papers by Md Rafi Haider Breakdown of academic impact, for papers by E. J. Tavares da Silva Breakdown of academic impact, for papers by Muhammad Athar Abbasi Breakdown of academic impact, for papers by Hinna Hamid Breakdown of academic impact, for papers by Aneela Maalik Breakdown of academic impact, for papers by M. J. Nanjan
Rankless by CCL
2026